PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma

@inproceedings{Valenti2013PNPLA3IP,
  title={PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma},
  author={Luca Valenti and Benedetta Maria Motta and Giorgio Soardo and Massimo Iavarone and Benedetta Donati and Angelo Sangiovanni and Alessia Carnelutti and Paola Dongiovanni and Raffaela Rametta and Cristina Bertelli and Floriana Facchetti and Massimo Colombo and Silvia Fargion and Anna Ludovica Fracanzani},
  booktitle={PloS one},
  year={2013}
}
BACKGROUND & AIMS Aim of this study was to evaluate whether the PNPLA3 I148M polymorphism, previously associated with hepatocellular carcinoma (HCC) risk, influences the clinical presentation of HCC and survival. METHODS we considered 460 consecutive HCC patients referred to tertiary care centers in Northern Italy, 353 with follow-up data. RESULTS Homozygosity for PNPLA3 148M at risk allele was enriched in HCC patients with alcoholic liver disease or nonalcoholic fatty liver disease (ALD… CONTINUE READING
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Similar Papers

Loading similar papers…